Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.

Authors:
Gupta SK; Garg A; Bär C; Chatterjee S; Foinquinos A and 4 more

Journal:
Circ Res

Publication Year: 2017

DOI:
10.1161/CIRCRESAHA.117.311335

PMCID:
PMC5771684

PMID:
29133306

Journal Information

Full Title: Circ Res

Abbreviation: Circ Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures T. Thum, J. Fiedler, and S.K. Gupta have filed and licensed patents about noncoding RNAs. T. Thum is founder of Cardior Pharmaceuticals GmbH. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding This study is funded by the Deutsche Forschungsgemeinschaft (DFG) GU 1664-1-1 grant to S.K. Gupta. T. Thum received funding from the IFB-Tx (BMBF 01EO1302), the REBIRTH Excellence Cluster, Fondation Leducq (MIRVAD [MicroRNA-Based Therapeutic Strategies in Vascular Disease]), and the European Union–funded ERC (European Research Council) Consolidator Grant LongHeart."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025